Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05306743 · ClinicalTrials.gov registry record · NA

PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.

A NA study of Chronic Obstructive Pulmonary Disease, sponsored by Observational and Pragmatic Research Institute.

Recruiting
Registry status
NA
Development phase
126
Enrollment target
3
Study locations

NCT05306743: Recruiting NA study of Chronic Obstructive Pulmonary Disease, sponsored by Observational and Pragmatic Research Institute.

NCT05306743 is a NA study of Chronic Obstructive Pulmonary Disease that is actively recruiting participants, run by Observational and Pragmatic Research Institute. The registered enrollment target is 126 participants, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05306743, a NA study of Chronic Obstructive Pulmonary Disease, is actively recruiting participants, sponsored by Observational and Pragmatic Research Institute.

RECRUITING
Registry status
NA
Development phase
126 participants
Enrollment target
3
Study locations

Study Summary

A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.

Primary Outcome

To evaluate the effectiveness of the CONQUEST program on 1a) the annual rate of moderate or severe COPD exacerbations and on 2b) the annual rates of major adverse cardiac or respiratory events (during the outcome evaluation period).

Interventions

  • OTHER CONQUEST Quality Improvement Program

Study Locations (3)

Colorado

  • University of Colorado - Denver

New York

  • Mount Sinai - New York

Ohio

  • MetroHealth - Cleveland

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2022-09-23
Est. Completion 2026-12
Phase NA

What NCT05306743 shows while recruiting

NCT05306743 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 1 intervention - of which CONQUEST Quality Improvement Program is the first listed.

NCT05306743 reports a single indexed study location in Colorado, New York, Ohio.

Frequently Asked Questions

What is clinical trial NCT05306743 about?

NCT05306743 is a clinical study titled "PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.". A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.

What is the current status of trial NCT05306743?

This trial is currently recruiting. It is a NA study. The enrollment target is 126 participants. The study started on 2022-09-23. Estimated completion is 2026-12.

What conditions does trial NCT05306743 study?

This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.

What interventions are being tested in trial NCT05306743?

The interventions under investigation include: CONQUEST Quality Improvement Program (OTHER).

Who is sponsoring clinical trial NCT05306743?

This trial is sponsored by Observational and Pragmatic Research Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05306743 being conducted?

This trial has 3 study locations across Colorado, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Obstructive Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05306743's enrollment target sits among peer trials

126 46th of 86 higher than 40 of 86 other Chronic Obstructive Pulmonary Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Obstructive Pulmonary Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05306743, the US trial registry maintained by the National Library of Medicine. NCT05306743 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.